Suppr超能文献

转移性结直肠癌的治疗与生存:南澳大利亚主要公立医院三十年的经验

Metastatic Colorectal Cancer Treatment and Survival: the Experience of Major Public Hospitals in South Australia Over Three Decades.

作者信息

Roder David, Karapetis Christos S, Wattchow David, Moore James, Singhal Nimit, Joshi Rohit, Keefe Dorothy, Fusco Kellie, Buranyi-Trevarton Dianne, Sharplin Greg, Price Timothy J

机构信息

Centre for Population Health Research, University of South Australia, South Australia E-mail :

出版信息

Asian Pac J Cancer Prev. 2015;16(14):5923-31. doi: 10.7314/apjcp.2015.16.14.5923.

Abstract

BACKGROUND

Registry data from four major public hospitals indicate trends over three decades from 1980 to 2010 in treatment and survival from colorectal cancer with distant metastases at diagnosis (TNM stage IV).

MATERIALS AND METHODS

Kaplan-Meier product-limit estimates and Cox proportional hazards models for investigating disease-specific survival and multiple logistic regression analyses for indicating first-round treatment trends.

RESULTS

Two-year survivals increased from 10% for 1980-84 to 35% for 2005-10 diagnoses. Corresponding increases in five-year survivals were from 3% to 16%. Time-to-event risk of colorectal cancer death approximately halved (hazards ratio: 0.48 (0.40, 0.59) after adjusting for demographic factors, tumour differentiation, and primary sub-site. Survivals were not found to differ by place of residence, suggesting reasonable equity in service provision. About 74% of cases were treated surgically and this proportion increased over time. Proportions having systemic therapy and/or radiotherapy increased from 12% in 1980-84 to 61% for 2005-10. Radiotherapy was more common for rectal than colonic cases (39% vs 7% in 2005-10). Of the cases diagnosed in 2005-10 when less than 70 years of age, the percentage having radiotherapy and/or systemic therapy was 79% for colorectal, 74% for colon and 86% for rectum (and RS)) cancers. Corresponding proportions having: systemic therapies were 75%, 71% and 81% respectively; radiotherapy were 24%, 10% and 46% respectively; and surgery were 75%, 78% and 71% respectively. Based on survey data on uptake of offered therapies, it is likely that of these younger cases, 85% would have been offered systemic treatment and among rectum (and RS) cases, about 63% would have been offered radiotherapy.

CONCLUSIONS

Pronounced increases in survivals from metastatic colorectal cancer have occurred, in keeping with improved systemic therapies and surgical interventions. Use of radiotherapy and/or systemic therapy has increased markedly and patterns of change accord with clinical guideline recommendations.

摘要

背景

来自四家大型公立医院的登记数据显示了1980年至2010年这三十年中,诊断为伴有远处转移的结直肠癌(TNM分期IV期)的治疗和生存趋势。

材料与方法

采用Kaplan-Meier乘积限估计法和Cox比例风险模型来研究疾病特异性生存情况,并采用多元逻辑回归分析来表明首轮治疗趋势。

结果

两年生存率从1980 - 1984年的10%提高到2005 - 2010年诊断病例的35%。五年生存率相应地从3%提高到16%。在对人口统计学因素、肿瘤分化程度和原发亚部位进行调整后,结直肠癌死亡的事件发生风险时间大约减半(风险比:0.48(0.40,0.59))。未发现生存率因居住地点不同而存在差异,这表明在服务提供方面具有合理的公平性。约74%的病例接受了手术治疗,且这一比例随时间增加。接受全身治疗和/或放疗的比例从1980 - 1984年的12%增加到2005 - 2010年的61%。直肠癌病例接受放疗的情况比结肠癌病例更为常见(2005 - 2010年分别为39%和7%)。在2005 - 2010年诊断时年龄小于70岁的病例中,结直肠癌、结肠癌和直肠癌(及直肠乙状结肠交界处癌)接受放疗和/或全身治疗的百分比分别为79%、74%和86%。接受全身治疗的相应比例分别为75%、71%和81%;接受放疗的比例分别为24%、10%和46%;接受手术的比例分别为75%、78%和71%。根据所提供治疗的接受情况调查数据,在这些较年轻的病例中,可能有85%接受了全身治疗,在直肠癌(及直肠乙状结肠交界处癌)病例中,约63%接受了放疗。

结论

转移性结直肠癌的生存率显著提高,这与全身治疗和手术干预的改善相一致。放疗和/或全身治疗的使用显著增加,且变化模式符合临床指南建议。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验